237 related articles for article (PubMed ID: 34524657)
1. Genetic Analysis of iNKT Cell Development and Function.
Sahler J; Anannya O; Limper C; Imbiakha B; Pierpont T; August A
Methods Mol Biol; 2021; 2388():1-12. PubMed ID: 34524657
[TBL] [Abstract][Full Text] [Related]
2. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
3. Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant
Genardi S; Visvabharathy L; Cao L; Morgun E; Cui Y; Qi C; Chen YH; Gapin L; Berdyshev E; Wang CR
Front Immunol; 2020; 11():610010. PubMed ID: 33312179
[TBL] [Abstract][Full Text] [Related]
4. The ins and outs of type I iNKT cell development.
Shissler SC; Webb TJ
Mol Immunol; 2019 Jan; 105():116-130. PubMed ID: 30502719
[TBL] [Abstract][Full Text] [Related]
5. The effect of intracellular trafficking of CD1d on the formation of TCR repertoire of NKT cells.
Shin JH; Park SH
BMB Rep; 2014 May; 47(5):241-8. PubMed ID: 24755556
[TBL] [Abstract][Full Text] [Related]
6. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.
Maricic I; Girardi E; Zajonc DM; Kumar V
J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475
[TBL] [Abstract][Full Text] [Related]
7. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
Dasgupta S; Kumar V
Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
[TBL] [Abstract][Full Text] [Related]
8. Detection of Mouse Type I NKT (iNKT) Cells by Flow Cytometry.
Joshi V; Terabe M
Methods Mol Biol; 2021; 2388():87-99. PubMed ID: 34524664
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells.
Zajonc DM; Kronenberg M
Immunol Rev; 2009 Jul; 230(1):188-200. PubMed ID: 19594637
[TBL] [Abstract][Full Text] [Related]
10. Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid.
Arrenberg P; Halder R; Dai Y; Maricic I; Kumar V
Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10984-9. PubMed ID: 20534460
[TBL] [Abstract][Full Text] [Related]
11. Role of invariant natural killer T (iNKT) cells in systemic lupus erythematosus.
Godó M; Sessler T; Hamar P
Curr Med Chem; 2008; 15(18):1778-87. PubMed ID: 18691038
[TBL] [Abstract][Full Text] [Related]
12. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
Gerth E; Mattner J
Front Immunol; 2019; 10():1449. PubMed ID: 31293596
[TBL] [Abstract][Full Text] [Related]
13. Type II NKT Cells: An Elusive Population With Immunoregulatory Properties.
Singh AK; Tripathi P; Cardell SL
Front Immunol; 2018; 9():1969. PubMed ID: 30210505
[TBL] [Abstract][Full Text] [Related]
14. CD1d-unrestricted NKT cells are endowed with a hybrid function far superior than that of iNKT cells.
Farr AR; Wu W; Choi B; Cavalcoli JD; Laouar Y
Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12841-6. PubMed ID: 25143585
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic factors and CD1d1 but not CD1d2 expression levels control invariant natural killer T cell subset differentiation.
Amable L; Ferreira Martins LA; Pierre R; Do Cruseiro M; Chabab G; Sergé A; Kergaravat C; Delord M; Viret C; Jaubert J; Liu C; Karray S; Marie JC; Irla M; Georgiev H; Clave E; Toubert A; Lucas B; Klibi J; Benlagha K
Nat Commun; 2023 Dec; 14(1):7922. PubMed ID: 38040679
[TBL] [Abstract][Full Text] [Related]
16. Natural Killer T (NKT) Cells and Periodontitis: Potential Regulatory Role of NKT10 Cells.
Melgar-Rodríguez S; Cafferata EA; Díaz NI; Peña MA; González-Osuna L; Rojas C; Sierra-Cristancho A; Cárdenas AM; Díaz-Zúñiga J; Vernal R
Mediators Inflamm; 2021; 2021():5573937. PubMed ID: 34594157
[TBL] [Abstract][Full Text] [Related]
17. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
18. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
Hung JT; Huang JR; Yu AL
J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
[TBL] [Abstract][Full Text] [Related]
19. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapeutic strategies targeting natural killer T cell responses in cancer.
Shissler SC; Bollino DR; Tiper IV; Bates JP; Derakhshandeh R; Webb TJ
Immunogenetics; 2016 Aug; 68(8):623-38. PubMed ID: 27393665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
